Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers. | Front Immunol | 2023 | 38179042 | PubTator, text mining | PubMed |
| The significance of long non-coding RNAs in the pathogenesis, diagnosis and treatment of inflammatory bowel disease. | Precis Clin Med | 2023 | 38163004 | PubTator, text mining | PubMed |
| The role of macrophages in gastric cancer. | Front Immunol | 2023 | 38143746 | PubTator, text mining | PubMed |
| A Second Career for p53 as A Broad-Spectrum Antiviral? | Viruses | 2023 | 38140618 | PubTator, text mining | PubMed |
OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway. | Int J Mol Sci | 2023 | 38139364 | PubTator, text mining | PubMed |
| Insights into Zika Virus Pathogenesis and Potential Therapeutic Strategies. | Biomedicines | 2023 | 38137537 | PubTator, text mining | PubMed |
| Alu Methylation Patterns in Type 1 Diabetes: A Case-Control Study. | Genes (Basel) | 2023 | 38136971 | PubTator, text mining | PubMed |
| Type 17-specific immune pathways are active in early spondyloarthritis. | RMD Open | 2023 | 38123480 | PubTator, text mining | PubMed |
| COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer. | Technol Cancer Res Treat | 2023 | 38112409 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Potential targets of phytochemical immunomodulatory therapy in periodontitis immunopathogenesis: A narrative review. | Saudi Dent J | 2023 | 38107043 | PubTator, text mining | PubMed |
| A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. | Front Mol Biosci | 2023 | 38106991 | PubTator, text mining | PubMed |
| Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren's syndrome. | NPJ Syst Biol Appl | 2023 | 38102122 | PubTator, text mining | PubMed |
| A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. | Sci Rep | 2023 | 38086949 | PubTator, text mining | PubMed |
| Comparative characterization of microRNA-71 of Echinococcus granulosus exosomes. | Parasite | 2023 | 38084936 | PubTator, text mining | PubMed |
| Progress in diagnosis and treatment of difficult-to-treat asthma in children. | Ther Adv Respir Dis | 2023 | 38069568 | PubTator, text mining | PubMed |
| APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis. | Int J Mol Sci | 2023 | 38069117 | PubTator, text mining | PubMed |
| Extensive Alternative Splicing Patterns in Systemic Lupus Erythematosus Highlight Sexual Differences. | Cells | 2023 | 38067106 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
| Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma. | J Immunother Cancer | 2023 | 38040420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=13